Publikationen, an denen er mitarbeitet FRANCISCO LÓPEZ MEDRANO (145)

2024

  1. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  2. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

  3. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

  4. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  5. Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

    Transplant Infectious Disease

  6. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

  7. Reduction of Instrumentation-Related Spine Surgical Site Infections After Optimization of Surgical Techniques. A Single Center Retrospective Analysis

    Global Spine Journal, Vol. 14, Núm. 2, pp. 438-446

  8. Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department

    Journal of Medical Virology, Vol. 96, Núm. 10

  9. Spatial Relationship between a Regional Outbreak and a Higher-than-Expected Incidence of Leishmaniasis in Urban Southern Madrid, Spain

    The American journal of tropical medicine and hygiene, Vol. 111, Núm. 4, pp. 814-818

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

  2. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  3. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  4. Comprehensive analysis of current epidemiology, clinical features and Prognostic Factors of puerperal endometritis: A retrospective cohort analysis

    European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 18

  5. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9

  6. Previous use of statins does not improve the outcome of bloodstream infection after kidney transplantation

    Transplant Infectious Disease, Vol. 25, Núm. 5

  7. Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 12, pp. 1485-1497

  8. Proof of concept of a new device for the insertion of peripheral venous catheters in aseptic conditions

    Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, Vol. 237, Núm. 5, pp. 552-556

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. An exploratory analysis of C-X-C motif chemokine ligand 10 as a new biomarker of asymptomatic Leishmania infantum infection in solid-organ transplant recipients

    Journal of Infection, Vol. 84, Núm. 4, pp. 573-578

  3. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64